The platform is based on a beta-propiolactone (BPL)-inactivated, whole-virus approach - a modernised take on traditional vaccine technology, according to the NIH on Thursday.
The findings showed that 51 per cent of respondents in India have increased their use of digital technologies and data solutions since the outbreak of the pandemic.
